Botox for Chronic Migraine: The PREEMPT Protocol Explained
If you have chronic migraine (15 or more headache days per month), you've failed multiple preventive treatments, and your neurologist is talking to you about Botox injections, this article is for you.
Botox for migraine is not a repurposed cosmetic treatment. It's a treatment FDA-approved in 2010, EMA-approved, and used in headache clinics worldwide for chronic migraine prevention. The protocol used (PREEMPT) is ultra-standardized: 31 to 39 injections, 155 to 195 units, every 12 weeks, in 7 precise areas of the head and neck.
Clinical trial results are solid: average reduction of 8 to 9 headache days per month, with some specialized centers reporting up to 95% responder rates in optimized real-world protocols.
This article explains exactly how it works, who's eligible, what a session looks like, real-world efficacy, side effects, and the critical question of insurance coverage in the U.S.
What is botulinum toxin exactly?
OnabotulinumtoxinA (Botox® by Allergan/AbbVie, or competitors Dysport®, Xeomin®, etc.) is a purified neurotoxin produced by the bacterium Clostridium botulinum. At therapeutic doses, it's perfectly safe: used for over 30 years in medicine to treat dystonia, spasticity, strabismus, hyperhidrosis, and of course cosmetically for wrinkles.
Its primary mechanism: it blocks acetylcholine release at the neuromuscular junction, temporarily relaxing injected muscles.
But in migraine, the mechanism is more complex than this simple muscular action.
How Botox works on migraine
The anti-migraine effect of Botox was discovered by accident in the 1990s: patients treated for forehead wrinkles reported their migraines had decreased. Subsequent clinical studies confirmed the effect.
Documented mechanisms:
1. Inhibition of CGRP and substance P release
Botox reduces the release of CGRP (the central peptide in migraine) and substance P from sensory nerve endings. This is probably the main mechanism in migraine, more than simple muscular action.
Our article on CGRP migraine treatments details the central role of CGRP in triggering migraine.
2. Central sensitization reduction
Botox reduces peripheral and central sensitization of the nervous system, which characterizes chronic migraine. This is why it works even on migraines that don't have a primary muscular origin.
3. Ion channel modulation
Effect on TRPV1 and TRPA1 channels, involved in pain transmission.
4. Muscle relaxation (secondary effect)
Botox relaxes pericranial muscles (forehead, temples, neck), reducing trigger points, particularly useful for patients with strong muscular components (neck tension, bruxism).
The PREEMPT protocol: global standard
The PREEMPT protocol ("Phase III REsearch Evaluating Migraine Prophylaxis Therapy") is the absolute standard for Botox injections in chronic migraine. Based on two major Phase III clinical trials published in 2010 in Cephalalgia (PREEMPT 1 and PREEMPT 2), it has been adopted by the FDA, EMA, AAN, AHS, and all major headache societies worldwide.
Protocol specifications
- 155 units of onabotulinumtoxinA (Botox® Allergan/AbbVie) — extendable to 195 units for refractory cases following the "follow-the-pain" paradigm
- 31 to 39 injection sites
- 7 specific head and neck muscle areas: corrugator, procerus, frontalis, temporalis, occipitalis, cervical paraspinal, trapezius
- Intramuscular injections, precise depth per zone
- Very fine needles (30G), minimally painful
- Repeat every 12 weeks (every 3 months)
Session duration
10 to 30 minutes, outpatient, in the neurologist's office or headache clinic. No anesthesia needed. You leave immediately after. You can resume normal activities the same day (except intense exercise for 24h).
When you see results
- Onset of action: 1 to 2 weeks after the first injection
- Initial effect: visible by 4 weeks
- Full benefits: typically after 2 to 3 treatment cycles (about 6 months), not from the first session
This is critical: don't conclude failure after just one session. The protocol deserves at least 2 cycles before evaluation.
Who's eligible for Botox?
Botox for migraine is not for everyone. It's strictly reserved for severe, treatment-resistant chronic migraine.
Eligibility criteria (FDA + AHS 2021 consensus)
You're a potential candidate for Botox injections if you meet all of these criteria:
- Confirmed chronic migraine: 15 or more headache days per month, with headaches lasting 4+ hours per day, of which at least 8 are migraine days, for more than 3 months
- Failure of at least 2 preventive treatments from different classes (beta-blocker, topiramate, amitriptyline) at effective doses for 8+ weeks, OR intolerance/contraindication
- No contraindication to botulinum toxin
- Treatment by a neurologist or headache specialist trained in PREEMPT
Botox is NOT indicated for:
- Episodic migraine (fewer than 15 days/month) — efficacy not established in 7 placebo-controlled studies
- Isolated tension-type headache
- Pediatric migraine (under 18)
- Cluster headaches (limited evidence)
Our article on the migraine glossary explains the precise medical distinction between chronic and episodic migraine.
What's the real-world efficacy?
Key numbers from PREEMPT 1 and 2 (Dodick et al., 2010, on 1,384 patients):
Statistical results
- Average reduction: 8 to 9 headache days per month at week 24 from baseline (vs 6-7 with placebo)
- 50% responders (≥50% reduction in attacks): roughly 47-50% of patients
- 75% super-responders: roughly 20%
- Significant reduction in acute medication use
- Sustained efficacy over 3+ years in the COMPEL open-label extension trial
Real-world evidence (post-marketing)
A 10-year meta-analysis of real-world data (Affaitati et al., 2022, PMC) on chronic migraine confirms and sometimes exceeds the pivotal trial results:
- Strong real-world effectiveness across observational studies
- Lower discontinuation rates than oral preventives (like topiramate)
- Favorable safety profile maintained long-term
- Some specialized centers using modified PREEMPT paradigms report up to 95% responder rates for ≥50% improvement
When to judge efficacy
The standard protocol calls for reassessment after the first 2 sessions (so at 6 months). Criteria:
- ≥30-50% reduction in headache days per month → continue treatment
- <30% reduction → stop or change strategy
If you're a responder, treatment can be continued for years. Some patients attempt a gradual taper after 1-2 years of efficacy, sometimes maintaining the effect.
What a session actually looks like
Before the session
- Initial consultation with the neurologist to confirm indication and explain the protocol
- Bring your migraine diary from the past 3-6 months (crucial for baseline)
- Continue your regular medications without change
- No fasting needed
During the session
- Positioning (sitting or semi-reclined)
- Skin disinfection of scalp and neck
- Toxin reconstitution by the provider (Botox diluted in saline)
- Injections one by one in the 31-39 points per PREEMPT protocol
- Each injection takes 5 to 10 seconds, precise dose of 5 units
- Total duration: 10 to 30 minutes
Sensation during injection
Light pinches, comparable to mosquito bites. Very fine needles (30G) are used. Most patients tolerate it well without anesthesia.
The most sensitive areas: temples and frontalis muscle. Cervical areas are generally less painful.
After the session
- Possible minor bleeding at injection points (rare, lasts seconds)
- Possible minor bruising (fades in 5-7 days)
- Immediate return to normal activities
- Avoid intense exercise for 24h
- Avoid massaging or rubbing injected areas for 24h
Side effects: what to expect
Botox is very well tolerated in migraine. Side effects are generally mild and transient.
Common effects (>5% of patients)
- Neck pain or stiffness in the 48-72h post-injection
- Slight neck tightness
- Minor hematomas at injection sites
- Transient headaches in the 24-48h (paradoxically)
Less common effects (1-5%)
- Eyelid ptosis (slight drooping): spontaneously reversible in a few weeks
- Temporary asymmetry of the eyebrows
- Local muscle weakness in the neck (rare swallowing difficulty)
- Itching or local skin reactions
Rare effects
- Systemic allergic reactions (very rare)
- Dysphagia (difficulty swallowing): risk if injection too deep at cervical level
- Toxin diffusion beyond the injection site
- Anti-toxin antibodies: very rare, can reduce efficacy of future injections
Important to know
- Muscular effects are 100% reversible: if you don't like the effect, in 3-4 months it's back to normal
- Aesthetic appearance changes little with the PREEMPT protocol (doses aren't distributed to erase wrinkles, that's a different protocol)
- You can wear makeup the next day
Absolute contraindications
- Pregnancy and breastfeeding
- Myasthenia gravis or Lambert-Eaton syndrome (neuromuscular diseases)
- Amyotrophic lateral sclerosis (ALS)
- Known allergy to botulinum toxin or human albumin
- Active skin infection at injection areas
The cost question: insurance and access
List prices
Without insurance, Botox treatment is expensive:
- Botox® (onabotulinumtoxinA) at 155 units: roughly $1,200-1,500 for the drug per session
- Administration fee (specialist + procedure): $400-800 per session
- Total per session: roughly $1,600-2,300
- Annual cost (4 sessions): up to $8,000-9,000 without insurance
How most patients actually pay
In practice, most U.S. patients pay much less through:
- Commercial insurance coverage: most plans cover Botox for chronic migraine after step therapy (usually requires failure of 2 oral preventives first)
- BOTOX® Savings Program from AbbVie: eligible commercially insured patients can pay as little as $0 per session, with savings up to $4,000 per year
- Medicare and Medicaid coverage: variable, often covered with prior authorization
- Patient assistance programs for uninsured or underinsured patients
Always check the AbbVie/BOTOX ONE official site for the latest savings program terms and eligibility.
Practical conditions
- Prescription reserved for neurologists or headache specialists trained in PREEMPT
- Treatment must be done in a clinical setting (headache clinic, neurology office, hospital outpatient department)
- No insurance coverage in cosmetic settings for this indication
International access
Botox for chronic migraine is also EMA-approved (Europe), MHRA-approved (UK), Health Canada-approved, and approved in most major markets. Reimbursement varies by country — fully or partially covered in many European countries (France, Germany, Italy, Spain) under specific protocols.
Botox vs CGRP Inhibitors: how to choose?
You're eligible for both Botox and CGRP inhibitors? Good news, you have two options. Here's how they compare.
Botox advantages
- Often better insurance coverage for chronic migraine (especially in commercial plans)
- Localized effect, no systemic circulation
- 15+ years of safety data
- No self-injection at home (some prefer in-office treatment)
- Additional effect on neck tension and bruxism
CGRP inhibitor advantages
- At-home self-injection (more convenient for some)
- Single injection instead of 31-39
- No cosmetic effect (no ptosis, no asymmetry)
- Sometimes faster onset (1-4 weeks)
- Also effective in episodic migraine (not just chronic)
And combination?
For the most severe, treatment-resistant chronic migraines, some neurologists combine Botox + anti-CGRP. Preliminary data show additive efficacy. This is a specialist decision to discuss with a headache center.
Our article on CGRP migraine treatments details the 4 available molecules and their specifics.
Tracking: essential for evaluation
Like for any preventive migraine treatment, objective tracking is crucial to evaluate whether Botox is working for you.
Why it's even more important for Botox
- Delayed effect: don't judge after 1 week, judge after 2-3 months
- Variable effect: first sessions may be less effective than later ones
- Cost and invasiveness: you want to know precisely if the effort is worth it
- Medical decision: your neurologist will decide to continue/stop based on your numbers, not your impressions
Indicators to track before and during
- Number of migraine days per month (primary metric)
- Number of headache days (all types)
- Average attack intensity (1-10)
- Average attack duration
- Number of triptan/analgesic doses
- Impact on your life (MIDAS or HIT-6 scale, at appointments)
- Side effects experienced
Baseline is essential
You need 2-3 months of pre-treatment data to establish baseline and measure real difference. Otherwise, impossible to know if attack reduction is due to Botox, something else, or natural variability.
That's exactly what we built Mellow for: track each attack in seconds, automatically calculate your monthly statistics, and generate a report ready to present to your neurologist at the 6-month reassessment. With precise numbers, the medical decision is clear and grounded. Without, it's guesswork.
Sources
Dodick DW, Turkel CC, DeGryse RE, Aurora SK, Silberstein SD, Lipton RB, Diener HC, Brin MF. — OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program. Headache, 2010;50(6):921-936.
Diener HC, Dodick DW, Aurora SK, et al. — OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial. Cephalalgia, 2010;30(7):804-814.
Aurora SK, Dodick DW, Diener HC, et al. — OnabotulinumtoxinA for chronic migraine: efficacy, safety, and tolerability in patients who received all five treatment cycles in the PREEMPT clinical program. Acta Neurologica Scandinavica, 2014;129(1):61-70. (COMPEL long-term data.)
Affaitati G, Costantini R, Fiordaliso M, et al. — Effectiveness of onabotulinumtoxinA (BOTOX®) for the preventive treatment of chronic migraine: A meta-analysis on 10 years of real-world data. PMC, 2022. ncbi.nlm.nih.gov
American Migraine Foundation — Botulinum Toxin for Migraine. americanmigrainefoundation.org
American Headache Society — The American Headache Society Consensus Statement: Update on integrating new migraine treatments into clinical practice. Headache, 2021. headachejournal.onlinelibrary.wiley.com
BOTOX® (onabotulinumtoxinA) — Official Allergan/AbbVie prescribing information for chronic migraine. botoxone.com
National Headache Foundation — Botox® for Chronic Migraine. headaches.org
Related articles
CGRP Inhibitors: The New Generation of Migraine Preventive Treatments
Aimovig, Ajovy, Emgality, Vyepti: complete guide to anti-CGRP monoclonal antibodies, migraine-specific preventives. Efficacy, side effects, prescription, insurance.
Triptans Explained: A Complete Guide to These Anti-Migraine Drugs
Sumatriptan, zolmitriptan, rizatriptan: how triptans work, which one to choose, side effects, contraindications. The complete guide.